Polycythemia Vera Treatment Market Trends

Growth Drivers

• Rising Awareness about Disease – There is a growing awareness about polycythemia vera among healthcare professionals and the general public. This is leading to more patients being diagnosed with the disease and seeking treatment.
• Escalating Healthcare Expenditure – The increasing healthcare expenditure in developed and developing countries is also driving the expansion of the polycythemia vera treatment sector. This is owing to patients with this disorder require regular monitoring and treatment which can be expensive. In India, the current health spending is USD 660 Billion, whereas the current capital expenditure is USD 68 billion. According to a poll, the Union government's portion of the Government Health Expenditure (GHE) is 34.3% and the state governments' share is 65.7%.
• Growing Trend for Telemedicine – The increasing trend for telemedicine and digitalization in the medicine sector is predicted to offer lucrative growth opportunities in polycythemia vera treatment market. With the access to virtual consultation there is an option for people suffering with PV to get their treatment via virtual mode.

Challenges

• Strict Standards Required – The regulatory requirements for the approval of new treatments for polycythemia vera are strict. This can delay the introduction of new treatments into the market.

• Side Effects of Treatment

• High Cost of Treatment